Table 1.
Baseline characteristics of enrolled patients
| Parameter | Value N = 92 |
|---|---|
| Age (years) | 63 ± 13 |
| Female gender | 33 (36%) |
| History of atrial fibrillation | 62 (67%) |
| Paroxysmal (self‐terminating within 48 hours) | 44 (71% of 62) |
| Persistent (>7 days or requiring cardioversion) | 16 (26%) |
| Permanent | 2 (3%) |
| Main indication for insertable cardiac monitor | |
| Symptomatic or asymptomatic atrial fibrillation | 44 (48%) |
| Cryptogenic stroke | 15 (16%) |
| Syncope or presyncope | 33 (36%) |
| Heart failure status | |
| No history of heart failure | 63 (68%) |
| NYHA class I | 14 (15%) |
| NYHA class II | 9 (10%) |
| NYHA class III | 6 (7%) |
| Comorbidities | |
| Hypertension | 58 (63%) |
| Coronary artery disease | 16 (17%) |
| Valvular heart disease | 9 (10%) |
| Stroke | 15 (16%) |
| Transient ischemic attack | 3 (3%) |
| Thyroidism | 7 (8%) |
| Chronic obstructive pulmonary disease | 4 (4%) |
| Diabetes mellitus | 13 (14%) |
| Renal insufficiency | 11 (12%) |
Data are mean ± standard deviation or number (percent).
NYHA = New York Heart Association.